Capital is rotating out of AI capex into areas it starved for two years. Health care, airlines, defense and metals are where the market wants to be for the six weeks to the December 9 Fed meeting; gold and silver are bought on every dip. Risk is still being taken elsewhere: if S&P futures hold 7,700, the rotation carries the index; if they lose it, this was a correction in disguise. x.com 

Blue-chip dividend stocks seem to benefit from capital rotating out of weakening large-cap tech. They strengthen when QQQ weakens, or at least temporarily absorb some of that outflow; tech weakness and blue-chip or value gains have shown a one-for-one same-day relationship right now. x.com  x.com 

Software's relative strength and sound finances make institutional rotation from semis plausible. It could lead while semis consolidate, despite slow growth at some firms; the market rewards cash flow, healthy balance sheets and manageable debt. Salesforce, ServiceNow, Palantir, Shopify and Workday hold up; SAP's cloud and AI shift, Instacart's massive 10-month base, Veeva's massive five-year base and Atlassian's Stage 2 strength add to the case. Semis may still rally; the view can change. x.com  … Show more

Money is likely to rotate from crowded, richly valued AI hardware into undervalued large-cap AI beneficiaries in software, fintech and power. Microsoft's Copilot monetization is just starting, Oracle's cloud is accelerating at a discount to hyperscalers, ServiceNow gains from agentic automation, Snowflake's valuation is long compressed, and Salesforce is overlooked. SoFi gains from rate cuts, Robinhood from crypto and options, and Constellation and Vistra from power, AI's bottleneck. x.com 

Eli Lilly's GLP-1 and metabolic franchise can compound demand and cash flows while rate fears punish leveraged AI stories. It is preferable as a defensive-growth holding into its October 29 earnings over chasing a chip bounce. Continued healthcare volume leadership would support the sleeve; if semiconductors reclaim leadership first, the rotation is already crowded the other way. x.com  x.com 

Constellation Software, Microsoft and S&P Global deserve higher prices than they trade at after correcting in June, and current levels could be good long-term entries. Near-term headwinds remain: as long as semiconductors and memory lead the market, SaaS will perform poorly, with many hedge funds and institutions long semis and short SaaS. x.com 

UnitedHealth and healthcare look set to outperform through year-end, helped by midterm-year seasonality and defensive appeal. Over the last 20 years healthcare has generally done well from July through December in midterm election years. If the S&P 500 rolls into a bear market, UnitedHealth could outperform as investors rotate into defensive sectors. The bull case holds if medical cost ratios fall from AI and GLP-1 use and institutions rotate back into healthcare. x.com 

High-quality software stocks such as ServiceNow, Cloudflare, Figma and Palantir look set to gain as money eventually rotates out of crowded semis, memory, data centers, AI infrastructure, space and defense. Software is underloved, and these names rose in sympathy with Snowflake's strong earnings, possibly the start of a rotation. The quiet third month of the quarter is a good time to position for gains into mid-July earnings, and insider buying is a signal worth following. x.com 

Money should rotate from software back into semiconductors as software multiples get frothier, a contrarian call against the current narrative that SaaS has an AI tailwind. x.com 

Quality software has room to run and semiconductors' correction has more to go, because positioning is unwinding from opposite extremes. Semiconductors entered the week at the 100th percentile of positioning and software at the 0th, so the rotation is a correction in the most crowded trade. The KOSPI fell 5.5%, with SK Hynix down 9%. AI demand has not changed, but positioning must clear first: stay long Snowflake, Datadog, Fortinet and CrowdStrike, and reduce semis into any bounce. x.com